Search Results - "CHRISTIE, Jason D."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors by Olthoff, Kim M., Kulik, Laura, Samstein, Benjamin, Kaminski, Mary, Abecassis, Michael, Emond, Jean, Shaked, Abraham, Christie, Jason D.

    Published in Liver transplantation (01-08-2010)
    “…Translational studies in liver transplantation often require an endpoint of graft function or dysfunction beyond graft loss. Prior definitions of early…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    PCSK9 is a critical regulator of the innate immune response and septic shock outcome by Walley, Keith R, Thain, Katherine R, Russell, James A, Reilly, Muredach P, Meyer, Nuala J, Ferguson, Jane F, Christie, Jason D, Nakada, Taka-aki, Fjell, Chris D, Thair, Simone A, Cirstea, Mihai S, Boyd, John H

    Published in Science translational medicine (15-10-2014)
    “…A decrease in the activity of proprotein convertase subtilisin/kexin type 9 (PCSK9) increases the amount of low-density lipoprotein (LDL) receptors on liver…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Lung size mismatch and primary graft dysfunction after bilateral lung transplantation by Eberlein, Michael, MD, PhD, Reed, Robert M., MD, Bolukbas, Servet, MD, Diamond, Joshua M., MD, MS, Wille, Keith M., MD, Orens, Jonathan B., MD, Brower, Roy G., MD, Christie, Jason D., MD, MS

    “…Background Donor-to-recipient lung size matching at lung transplantation (LTx) can be estimated by the predicted total lung capacity (pTLC) ratio (donor…”
    Get full text
    Journal Article
  20. 20